Ozempic Injury Suits Consolidated In Eastern Pa. MDL

By P.J. D'Annunzio · February 5, 2024, 6:49 PM EST

The Judicial Panel on Multidistrict Litigation has moved 55 MDL cases over Ozempic and similar drugs to the Eastern District of Pennsylvania, centralizing the litigation that claims Novo Nordisk A/S and...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Order

Case Information

Case Title

IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation

Case Number

Court

Judicial Panel on Multidistrict Litigation

Nature of Suit

Date Filed

December 01, 2023

Recent Articles By P.J.

May 17, 2024
Philly Surgeon Settles Sex Bias Case With Jefferson Hospital
May 15, 2024
Former Sandoz Executive Avoids Prison In Price-Fixing Case
May 14, 2024
Hospitals Liable For Failing To Admit Killer, Pa. Justices Told
April 22, 2024
Citing Cozen O'Connor Ties, Pa. Judge Leaves Bias Case
April 15, 2024
Geico Must Arbitrate Fraud Claims Against Chiropractors
April 05, 2024
Surgeon Denied Atty Fees After Erasure of $15M Sex Bias Win
April 02, 2024
3rd Circ. Preview: Black Lung, Back Pay On Tap In April
March 22, 2024
Final OK Sought For Economic Loss Deal In CPAP Recall MDL
March 21, 2024
3rd Circ. Agrees Investors Have No Case Against Vax Maker
March 05, 2024
FDA Rejection Of Fosamax's Label Fix Not Final, 3rd Circ. Told